USE OF IL-23 AND IL-27 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE

• 收藏
• 分享

专利权人:

THE GOVERNMENT OF THE UNITED STATES OF AMERICA ASREPRESENTED BY THE SECRETARY OF THE DEPARTMENT OFHEALTH AND HUMAN SERVICES

发明人:

申请号：

NZ59526206

公开号：

NZ595262A

申请日:

2006.08.30

申请国别(地区):

NZ

年份:

2013

代理人:

摘要：

Disclosed is the use of an IL-23 antagonist for the preparation of a pharmaceutical composition for the treatment of an autoimmune ocular inflammatory disease (AOID) in a patient, wherein the IL-23 antagonist is a monoclonal antibody or a monoclonal 5 antibody fragment, wherein the IL-23 antagonist binds to and inhibits the activity of IL-23p19 or IL-23R.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/